Fig. 2From: Should RECOVERY have used response adaptive randomisation? Evidence from a simulation studyThe proportion of patients receiving dexamethasone across the trial for FR and cohort-level RAR frameworks. Vertical line at 42.5% trial progress represents the end of the burn-in period, with bars dotted bars representing +/− 1 standard deviation for each allocationBack to article page